Xwell (XWEL) Research & Development (2010 - 2023)

Xwell's (XWEL) quarterly Research & Development came in at $273000.0 in Q3 2023, down 63.16% year-on-year from $741000.0 in Q3 2022, and up 33.82% quarter-over-quarter from $204000.0 in Q2 2023.

Xwell (XWEL) Research & Development (2010 - 2023) Analysis & Trends

Xwell has disclosed Research & Development across 9 years of filings, most recently posting $273000.0 for Q3 2023.

  • Research & Development for Q3 2023 came in at $273000.0, down 63.16% year-over-year; the trailing twelve-month figure through Sep 2023 was $2.1 million (down 74.83% YoY), and the FY2014 annual result was $889000.0, down 41.2% from the prior year.
  • Research & Development came in at $273000.0 for Q3 2023 at Xwell, up from $204000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $839000.0 in Q2 2022 to a low of $204000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn 96.00 Mn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn 336.00 Mn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn 387.00 Mn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn 65.79 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn 126.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn -
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn 210.70 Mn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn 240.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn 51.28 Mn
10 Xwell 9.10 Mn 1.98 Mn 2.35 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 273,000.00
Jun 30, 2023 204,000.00
Sep 30, 2022 741,000.00
Jun 30, 2022 839,000.00
Sep 30, 2017 3.90 Mn
Jun 30, 2017 2.69 Mn
Mar 31, 2017 2.96 Mn
Sep 30, 2016 1.55 Mn
Jun 30, 2016 2.18 Mn
Mar 31, 2016 1.13 Mn
Dec 31, 2014 219,000.00
Sep 30, 2014 228,000.00
Jun 30, 2014 217,000.00
Mar 31, 2014 225,000.00
Dec 31, 2013 233,000.00
Sep 30, 2013 542,000.00
Jun 30, 2013 467,000.00
Mar 31, 2013 270,000.00
Dec 31, 2012 -454,000.00
Sep 30, 2012 997,000.00